Dr. Lal PathLabs Limited (NSE: LALPATHLAB) reported a Revenue from Operations of ₹489.4 Crores, a decline of 1.5% from the previous year. The Consolidated Net Profit for the business also decreased by 8% year over year, to ₹53.6 Crore from ₹58.2 Crore. Earnings per Share is ₹6.35 for this quarter.
Dr. Lal PathLabs Limited Q3 FY23; Net Profit Down By 8%
Tags: Healthcare Services
Related Post
- Kellton Tech Solutions Limited posts double-digit Q3 FY26 growth as digital transformation drives revenue; margins improve
Kellton Tech Solutions Limited (NSE: KELLTONTEC, BSE: 519602) reported double-digit year-on-year growth in revenue and…
-
Inox Green Energy Services Limited approves Q3 FY26 results and reappoints whole-time director
Inox Green Energy Services Limited (NSE: INOXGREEN, BSE: 543667) said its board approved the unaudited…
-
Huhtamaki India Limited reports flat Q4 2025 sales as margins improve on favorable mix and efficiency gains
Huhtamaki India Limited (NSE: HUHTAMAKI, BSE: 509820) reported broadly flat revenue in the fourth quarter…